Annual EBITDA
-$39.01 M
-$2.72 M-7.51%
December 31, 2023
Summary
- As of February 28, 2025, TMCI annual EBITDA is -$39.01 million, with the most recent change of -$2.72 million (-7.51%) on December 31, 2023.
- During the last 3 years, TMCI annual EBITDA has fallen by -$41.07 million (-1989.01%).
- TMCI annual EBITDA is now -1989.01% below its all-time high of $2.06 million, reached on December 31, 2020.
Performance
TMCI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.89 M
+$5.89 M+33.12%
September 30, 2024
Summary
- As of February 28, 2025, TMCI quarterly EBITDA is -$11.89 million, with the most recent change of +$5.89 million (+33.12%) on September 30, 2024.
- Over the past year, TMCI quarterly EBITDA has increased by +$2.77 million (+18.90%).
- TMCI quarterly EBITDA is now -409.39% below its all-time high of $3.84 million, reached on December 31, 2020.
Performance
TMCI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$48.33 M
+$2.77 M+5.42%
September 30, 2024
Summary
- As of February 28, 2025, TMCI TTM EBITDA is -$48.33 million, with the most recent change of +$2.77 million (+5.42%) on September 30, 2024.
- Over the past year, TMCI TTM EBITDA has dropped by -$10.34 million (-27.23%).
- TMCI TTM EBITDA is now -2400.14% below its all-time high of $2.10 million, reached on December 31, 2020.
Performance
TMCI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TMCI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.5% | +18.9% | -27.2% |
| 3 y3 years | -1989.0% | +25.1% | -41.3% |
| 5 y5 years | -1382.6% | +25.1% | -41.3% |
TMCI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -146.8% | at low | -444.4% | +33.1% | -205.7% | +5.4% |
| 5 y | 5-year | -1989.0% | at low | -409.4% | +33.1% | -2400.1% | +5.4% |
| alltime | all time | -1989.0% | at low | -409.4% | +33.1% | -2400.1% | +5.4% |
Treace Medical Concepts EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.89 M(-33.1%) | -$48.33 M(-5.4%) |
| Jun 2024 | - | -$17.78 M(+15.1%) | -$51.10 M(+18.2%) |
| Mar 2024 | - | -$15.45 M(+381.6%) | -$43.21 M(+10.8%) |
| Dec 2023 | -$39.01 M(+7.5%) | -$3.21 M(-78.1%) | -$39.01 M(+2.7%) |
| Sep 2023 | - | -$14.66 M(+48.2%) | -$37.98 M(+12.4%) |
| Jun 2023 | - | -$9.89 M(-12.0%) | -$33.81 M(-15.0%) |
| Mar 2023 | - | -$11.24 M(+414.9%) | -$39.78 M(+9.6%) |
| Dec 2022 | -$36.28 M | -$2.18 M(-79.2%) | -$36.28 M(-7.9%) |
| Sep 2022 | - | -$10.48 M(-33.9%) | -$39.41 M(+15.3%) |
| Jun 2022 | - | -$15.87 M(+104.7%) | -$34.20 M(+53.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.75 M(+45.8%) | -$22.27 M(+40.9%) |
| Dec 2021 | -$15.81 M(-865.5%) | -$5.32 M(+0.9%) | -$15.81 M(+137.7%) |
| Sep 2021 | - | -$5.27 M(+33.6%) | -$6.65 M(+498.5%) |
| Jun 2021 | - | -$3.94 M(+207.0%) | -$1.11 M(-166.2%) |
| Mar 2021 | - | -$1.28 M(-133.4%) | $1.68 M(-20.1%) |
| Dec 2020 | $2.06 M(-178.5%) | $3.84 M(+1312.9%) | $2.10 M(-220.6%) |
| Sep 2020 | - | $272.00 K(-123.6%) | -$1.74 M(-13.5%) |
| Jun 2020 | - | -$1.15 M(+33.6%) | -$2.01 M(+133.6%) |
| Mar 2020 | - | -$862.00 K | -$862.00 K |
| Dec 2019 | -$2.63 M | - | - |
FAQ
- What is Treace Medical Concepts annual EBITDA?
- What is the all time high annual EBITDA for Treace Medical Concepts?
- What is Treace Medical Concepts annual EBITDA year-on-year change?
- What is Treace Medical Concepts quarterly EBITDA?
- What is the all time high quarterly EBITDA for Treace Medical Concepts?
- What is Treace Medical Concepts quarterly EBITDA year-on-year change?
- What is Treace Medical Concepts TTM EBITDA?
- What is the all time high TTM EBITDA for Treace Medical Concepts?
- What is Treace Medical Concepts TTM EBITDA year-on-year change?
What is Treace Medical Concepts annual EBITDA?
The current annual EBITDA of TMCI is -$39.01 M
What is the all time high annual EBITDA for Treace Medical Concepts?
Treace Medical Concepts all-time high annual EBITDA is $2.06 M
What is Treace Medical Concepts annual EBITDA year-on-year change?
Over the past year, TMCI annual EBITDA has changed by -$2.72 M (-7.51%)
What is Treace Medical Concepts quarterly EBITDA?
The current quarterly EBITDA of TMCI is -$11.89 M
What is the all time high quarterly EBITDA for Treace Medical Concepts?
Treace Medical Concepts all-time high quarterly EBITDA is $3.84 M
What is Treace Medical Concepts quarterly EBITDA year-on-year change?
Over the past year, TMCI quarterly EBITDA has changed by +$2.77 M (+18.90%)
What is Treace Medical Concepts TTM EBITDA?
The current TTM EBITDA of TMCI is -$48.33 M
What is the all time high TTM EBITDA for Treace Medical Concepts?
Treace Medical Concepts all-time high TTM EBITDA is $2.10 M
What is Treace Medical Concepts TTM EBITDA year-on-year change?
Over the past year, TMCI TTM EBITDA has changed by -$10.34 M (-27.23%)